Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × Salvage Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Hodgkin Disease 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Radiosurgery 24 Magnetic Resonance Spectroscopy 20 Temozolomide 12 pembrolizumab 10 Bevacizumab 9 Specimen Handling 8 Radiotherapy 6 Nivolumab 6 Ipilimumab 6 Magnetic Resonance Imaging 5 Cyclophosphamide 5 Capecitabine 5 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 fluoromisonidazole 2 binimetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡